Patent 12005220 was granted and assigned to VeraDermics on June, 2024 by the United States Patent and Trademark Office.
The application provides a dissolvable microneedle device to deliver immune stimulants to the skin. The application also provides a method of treating a skin condition comprising applying a dissolvable microneedle device to the skin.